US Patent Issued to Handa Therapeutics on Oct. 7 for "Amorphous solid dispersions of dasatinib and uses thereof" (Minnesota Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,891, issued on Oct. 7, was assigned to Handa Therapeutics LLC (San Jose, Calif.).

"Amorphous solid dispersions of dasatinib and uses thereof" was invented by Christian F. Wertz (Saint Louis Park, Minn.) and Tzehaw Chen (Corcoran, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor dasatinib. The pharmaceutical compositions may be used in methods of treating a proliferative disorder such as cancer, or in methods of delivering dasatinib to patients without regard to whether the patient is concurrently administered a gastric acid-reducing agent, or without regar...